Загрузка...
Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
Immune thrombocytopenia (ITP) is a disease of heterogenous origin characterized by low platelet counts and an increased bleeding tendency. Three disease phases have been described: newly diagnosed (≤ 3 months after diagnosis), persistent (> 3–12 months after diagnosis), and chronic (> 12 month...
Сохранить в:
| Опубликовано в: : | Ann Hematol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310729/ https://ncbi.nlm.nih.gov/pubmed/34308495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-021-04590-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|